Catalyst Wire Dossier Catalyst Wire Dossier

Zervimesine

CT1812 · Cognition Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zervimesine, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program for CT1812 (Zervimesine)

See pricing